GRMOVER vs NATHBIOGEN: Stock Comparison
GRM Overseas Limited vs Nath Bio-Genes (India) Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
GRM Overseas Limited is the larger company by market capitalisation. GRM Overseas Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Nath Bio-Genes (India) Limited shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of GRM Overseas Limited and Nath Bio-Genes (India) Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| Live Price | ₹90.2 | ₹161.13 |
| Day Change | 0.37% | 4.19% |
| Volume | 1.53 L | 19,108 |
| 52-Week High | ₹517.7 | ₹204 |
| 52-Week Low | ₹81.95 | ₹126.15 |
| Distance from 52W High | -82.58% | -21.01% |
Valuation
| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| Market Cap | ₹1,869 Cr | ₹301 Cr |
| P/E Ratio | 25.16x | 7.43x |
| P/B Ratio | 3.11x | 0.45x |
| EPS | ₹7.85 | ₹20.97 |
| Book Value | ₹65.42 | ₹304.36 |
| Dividend Yield | 0% | 1.23% |
Growth
| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 105% | -1% |
| EPS Growth (TTM YoY) | 137.8% | 0% |
| Qtr Sales Growth | 105% | -0.73% |
| Qtr Profit Growth | 5.52% | -101% |
Profitability & Leverage
| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| ROE | 14.5% | 5.47% |
| ROCE | 14% | 7.1% |
| Net Margin | 4.22% | 9.35% |
| Operating Margin | 5.1% | 11.8% |
| Debt to Equity | 0.61x | 0.2x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | GRMOVER | NATHBIOGEN |
|---|---|---|
| Promoter Holding | 62.51%▲ 0.12 pp | 45.6% |
| FII Holding | 9.5%▲ 0.06 pp | 0.23%▼ 0.08 pp |
| DII Holding | 2.91%▼ 0.22 pp | 0.01% |
| Public Holding | 25.08%▲ 0.04 pp | 54.17%▲ 0.09 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRM Overseas Limited and Nath Bio-Genes (India) Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.